Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Search results for:

toripalimab-tpzi

toripalimab-tpzi
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Loqtorzi INJECTION, INTRAVENOUS 40 mg/mL      
Comments:

Restricted to oncologist use in the hospital outpatient setting. May use as patient’s own medication if distributed through a specialty pharmacy program or PAP.

 

 

 

 

 

 

 

Reviewed: May 2026                       

Toripalimab-tpzi (LOQTORZI) Spotlight.pdf                               

Last updated: Jun. 16, 2026






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved